1.Examine strengths and weaknesses of dual vs triple therapy in patients with COPD
2.Judge whether the current evidence warrants any change in treating patients with COPD in routine clinical practice.
3. Understand risk of a fib by age and standard cardiac risk factors
4. Understand how this risk is potentially modifiable
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation